SCHEDULE: Forian Inc. Receives $2.10/Share Take-Private Offer

A consortium led by CEO Max Wygod has proposed to acquire all outstanding shares of Forian Inc. not currently owned by them for $2.10 per share in cash, representing a 19% premium.

Summary

• A consortium, led by Max Wygod (CEO and Executive Chair of Forian Inc.), has submitted a non-binding proposal to acquire all outstanding shares of common stock of Forian Inc. not currently owned by them.
• The proposed offer price is $2.10 per share in cash.
• This offer represents a 19% premium to Forian Inc.'s closing price as of August 22, 2025.
• The consortium, which includes inside directors Adam Dublin and Shahir Kassam-Adams, collectively represents a majority of the company's outstanding shares, holding in excess of approximately 63%.
• The rationale for the transaction includes addressing low liquidity, slow recognition of value in public markets, valuation disparity with private peers, and the expense/burden of public company reporting requirements (e.g., Sarbanes-Oxley compliance).
• The transaction is anticipated to be a two-step process: a cash tender offer followed by a short-form merger.
• Financing for the transaction is expected to come from a combination of personal resources of consortium members, third-party financing, and the company's net cash at closing.
• The proposal is non-binding and subject to satisfactory completion of customary due diligence and approval by a special committee of independent directors of Forian Inc.'s Board.
• If consummated, Forian Inc. would be delisted from the Nasdaq Stock Market and its registration under the Securities Exchange Act of 1934 would be terminated.

Sentiment

Score: 8

Explanation: The proposal offers a significant premium to current trading levels and aims to address structural issues like low liquidity and high public company costs, which is generally positive for shareholders seeking an exit. The strong insider ownership in the consortium also suggests a high probability of the deal closing. However, it is non-binding and subject to conditions, introducing some uncertainty.

Positives

• The offer provides immediate liquidity and certainty of value for public stockholders.
• The proposed $2.10 per share represents a substantial 19% premium to the closing price as of August 22, 2025.
• Taking the company private would eliminate the significant expense, distraction, and administrative burden of quarterly reporting requirements and Sarbanes-Oxley compliance.
• The transaction aims to address the issue of low public float, which the consortium believes depresses liquidity and slows value recognition.
• The consortium, holding over 63% of outstanding shares, indicates strong internal support and a high likelihood of the transaction proceeding.
• The consortium is highly confident that the necessary financing can be arranged on an expedited basis.

Negatives

• The proposal is non-binding, meaning it can be withdrawn or modified at any time without legal obligation until definitive agreements are executed.
• The transaction is subject to satisfactory completion of due diligence, which could uncover issues or lead to changes in terms.
• Approval by a special committee of independent directors is a condition, and there is no guarantee they will approve the offer or may demand a higher price.
• Public shareholders will no longer participate in any potential future growth or upside of the company as a publicly traded entity.
• The transaction is conditioned upon the execution of satisfactory employment agreements with key management personnel, which could introduce complexities.

Risks

• The non-binding nature of the proposal means there is no legal obligation for the consortium or the company to complete the transaction.
• Failure to secure satisfactory third-party financing could prevent the transaction from closing.
• The special committee of the board of directors may not approve the proposal, or may require a higher offer price, leading to renegotiation or termination.
• Confirmatory due diligence could reveal unforeseen issues that lead to the withdrawal or modification of the offer.
• The requirement for satisfactory employment agreements with key management personnel introduces a potential point of negotiation and conditionality.
• Consortium members reserve the right to dispose of their securities in the open market or otherwise if the proposed transaction does not proceed, which could impact share price.

Future Outlook

The consortium intends to take Forian Inc. private, delisting it from Nasdaq and terminating its registration under the Securities Exchange Act of 1934. This move is expected to reduce administrative burdens and costs associated with being a public company, potentially improving operational focus and long-term value creation under private ownership, while providing immediate liquidity and a premium to current public shareholders. The consortium anticipates a prompt execution of a definitive agreement given their knowledge of the company and expects to arrange financing on an expedited basis.

Management Comments

• "We firmly believe that our proposed Transaction is in the best interests of Forian stockholders and other stakeholders, including its employees, clients, and end-users."
• "As a public company, Forian's low float depresses liquidity, slows the recognition of value in the markets, and widens the valuation disparity between the Company and comparable private peers."
• "We do not believe that it makes sense for Forian, to be subject to the expense, distraction and administrative burden of quarterly reporting requirements and Sarbanes-Oxley compliance obligations."
• "The Transaction addresses these considerations while providing public stockholders with immediate liquidity and certainty of value at a premium to current trading levels."
• "Given our knowledge of the Company, we expect to be in a position to execute a definitive agreement promptly."
• "We are highly confident the financing can be arranged on an expedited basis."
• "Given our history with Forian, we anticipate that the remaining due diligence will be limited in scope and can be completed quickly."

Industry Context

The proposed take-private transaction for Forian Inc. reflects a broader trend where companies with low public float, high compliance costs, and perceived undervaluation in public markets opt for private ownership. This strategy allows management to focus on long-term growth without the pressures of quarterly reporting and public market scrutiny, potentially unlocking value that public markets struggle to recognize, especially for niche or specialized data analytics companies like Forian. Such transactions often aim to streamline operations and reduce regulatory burdens, which can be particularly appealing for smaller public companies.

Comparison to Industry Standards

• NA

Corporate Governance

Related Party Transactions

• The take-private proposal is led by Max Wygod, who is the CEO and Executive Chair of Forian Inc.
• The consortium includes other inside directors, Adam Dublin and Shahir Kassam-Adams.
• The consortium members collectively own a majority (over 63%) of Forian Inc.'s outstanding shares, making this a significant related-party transaction where existing insiders are acquiring the remaining public shares.

Stakeholder Impact

• **Shareholders:** Public shareholders are offered immediate liquidity and a 19% premium over recent trading prices, but will no longer participate in the company's future growth as a public entity. Consortium members will consolidate ownership.
• **Employees:** The consortium states the transaction is in the best interests of employees. The transaction is conditioned upon the execution of satisfactory employment agreements with key management personnel, suggesting continuity for leadership.
• **Clients and End-users:** The consortium believes the transaction is in their best interests, implying a potential for continued or improved service, possibly due to reduced public company distractions and a focus on long-term strategy.
• **Creditors:** The transaction will be funded in part by third-party financing and the company's net cash, which could impact the company's balance sheet and leverage. Specific details on creditor impact are not provided.

Next Steps

• The Board of Directors of Forian Inc. is expected to establish a Special Committee of disinterested and independent directors to evaluate the proposal.
• The consortium will commence confirmatory due diligence of Forian Inc.
• Negotiation and execution of a definitive merger agreement between the consortium and Forian Inc.
• Following a definitive agreement, the consortium intends to commence a tender offer to acquire outstanding shares.
• A short-form merger will immediately follow the tender offer.
• Consortium members will negotiate and finalize an Investors Agreement and other definitive documents for the special purpose acquisition vehicle (SPV).

Key Dates

Recommendation

The offer of $2.10 per share represents a significant 19% premium to the closing price as of August 22, 2025, which is attractive for current shareholders. However, the proposal is explicitly non-binding and subject to several conditions, including satisfactory due diligence and approval by a special committee of independent directors. While the consortium's majority ownership suggests a high probability of the deal progressing, there remains a possibility of a higher counter-offer or the deal falling through. A 'hold' recommendation allows investors to benefit from the premium if the deal closes, while acknowledging the non-binding nature and potential for further developments, without locking into a 'buy' on a non-binding offer or 'sell' before the deal is finalized.

Keywords

Forian Inc., take-private, tender offer, merger, Max Wygod, consortium, stock acquisition, delisting, private ownership, corporate governance, shareholder value, SEC filing, Schedule 13D